Literature DB >> 28353280

LRRK2 and Autophagy.

Claudia Manzoni1,2, Patrick A Lewis3,4.   

Abstract

Leucine-rich repeat kinase 2 (LRRK2) has been implicated in a wide range of cellular processes, including the catabolic pathways collectively described as autophagy. In this chapter, the evidence linking LRRK2 to autophagy will be examined, along with how regulation of autophagy and lysosomal pathways may provide a nexus between the physiological function of this protein and the different diseases with which it has been associated. Data from cellular and animal models for LRRK2 function and dysfunction support a role in the regulation and control of autophagic pathways in the cell, although the extant results do not provide a clear indication as to whether LRRK2 is a positive or negative regulator of these pathways, and there are conflicting data as to the impact of mutations in LRRK2 causative for Parkinson's disease. Given that LRRK2 is a priority drug target for Parkinson's, the evidence suggesting that knockout or inhibition of LRRK2 can result in deregulation of autophagy may have important implications and is discussed in the context of our wider understanding of LRRK2.

Entities:  

Keywords:  Autophagosomes; Catabolism; LRRK2; Lysosomes; Macroautophagy; Parkinson’s disease

Mesh:

Substances:

Year:  2017        PMID: 28353280     DOI: 10.1007/978-3-319-49969-7_5

Source DB:  PubMed          Journal:  Adv Neurobiol


  16 in total

Review 1.  In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology.

Authors:  Scott C Vermilyea; Marina E Emborg
Journal:  Stem Cells Dev       Date:  2018-03-29       Impact factor: 3.272

2.  Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions.

Authors:  Julia Obergasteiger; Giulia Frapporti; Giulia Lamonaca; Sara Pizzi; Anne Picard; Alexandros A Lavdas; Francesca Pischedda; Giovanni Piccoli; Sabine Hilfiker; Evy Lobbestael; Veerle Baekelandt; Andrew A Hicks; Corrado Corti; Peter P Pramstaller; Mattia Volta
Journal:  Cell Death Discov       Date:  2020-06-08

Review 3.  Progress in the genetic analysis of Parkinson's disease.

Authors:  Andrew Singleton; John Hardy
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 4.  LRRK2 and Proteostasis in Parkinson's Disease.

Authors:  María Dolores Pérez-Carrión; Inmaculada Posadas; Javier Solera; Valentín Ceña
Journal:  Int J Mol Sci       Date:  2022-06-18       Impact factor: 6.208

5.  Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions.

Authors:  Julia Obergasteiger; Giulia Frapporti; Giulia Lamonaca; Sara Pizzi; Anne Picard; Alexandros A Lavdas; Francesca Pischedda; Giovanni Piccoli; Sabine Hilfiker; Evy Lobbestael; Veerle Baekelandt; Andrew A Hicks; Corrado Corti; Peter P Pramstaller; Mattia Volta
Journal:  Cell Death Discov       Date:  2020-06-08

6.  LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation.

Authors:  Dong Hwan Ho; A Reum Je; Haejin Lee; Ilhong Son; Hee-Seok Kweon; Hyung-Gun Kim; Wongi Seol
Journal:  Exp Neurobiol       Date:  2018-06-30       Impact factor: 3.261

7.  The Parkinson's disease-linked Leucine-rich repeat kinase 2 (LRRK2) is required for insulin-stimulated translocation of GLUT4.

Authors:  Natalja Funk; Marita Munz; Thomas Ott; Kathrin Brockmann; Andrea Wenninger-Weinzierl; Ralf Kühn; Daniela Vogt-Weisenhorn; Florian Giesert; Wolfgang Wurst; Thomas Gasser; Saskia Biskup
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

Review 8.  Alpha-Synuclein and LRRK2 in Synaptic Autophagy: Linking Early Dysfunction to Late-Stage Pathology in Parkinson's Disease.

Authors:  Giulia Lamonaca; Mattia Volta
Journal:  Cells       Date:  2020-04-30       Impact factor: 6.600

Review 9.  A new hypothesis for Parkinson's disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics.

Authors:  Julia Obergasteiger; Giulia Frapporti; Peter P Pramstaller; Andrew A Hicks; Mattia Volta
Journal:  Mol Neurodegener       Date:  2018-08-02       Impact factor: 14.195

10.  Analysis of macroautophagy related proteins in G2019S LRRK2 Parkinson's disease brains with Lewy body pathology.

Authors:  Adamantios Mamais; Claudia Manzoni; Iqra Nazish; Charles Arber; Berkiye Sonustun; Selina Wray; Thomas T Warner; Mark R Cookson; Patrick A Lewis; Rina Bandopadhyay
Journal:  Brain Res       Date:  2018-07-25       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.